Prognostic Significance of MSI and EBV Positivity in PD ‐ L1 Positive Gastric Cancer: A Systematic Review and Meta‐Analysis
Cancer Medicine · 2026-03 · 15 (3)
DOI: 10.1002/cam4.71711 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Medicine, online erschienen am 19.03.2026. Verfasst von Fausto Petrelli und 11 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Unit, ASST Bergamo Ovest, Treviglio, Italy. Hauptthemen laut MEDLINE: Stomach Neoplasms, Microsatellite Instability, B7-H1 Antigen, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Microsatellite instability (MSI), programmed death‐ligand 1 (PD‐L1) expression, and Epstein–Barr virus (EBV) positivity are emerging biomarkers in gastric cancer prognosis and treatment selection, particularly in immunotherapy. This review evaluates their prognostic significance through a systematic review and meta‐analysis.
Methods
Relevant studies from PubMed, EMBASE, and the Cochrane Library (January 2010 to December 2024) were analyzed. Studies included assessing MSI, PD‐L1, and EBV status in gastric cancer using immunohistochemistry, PCR, or in situ hybridization, and reported outcomes such as overall survival (OS), disease‐free survival (DFS), or progression‐free survival. Data extraction adhered to PRISMA guidelines, and pooled analyses were conducted using a random‐effects model (DerSimonian‐Laird method). Heterogeneity was assessed using I 2 statistics and Cochran's Q test.
Results
A total of 25 studies involving 6494 patients were reviewed. In localized gastric cancer, MSI‐high status was associated with significantly improved DFS (hazard ratio [HR], 0.42; 95% confidence interval [CI], 0.23–0.75; p = 0.004) but showed no significant impact on OS (HR, 0.78; 95% CI, 0.48–1.28; p = 0.33) compared to microsatellite stable/PD‐L1‐negative tumors. EBV‐positive/PD‐L1‐positive cancers demonstrated a prognosis similar to EBV‐negative/PD‐L1‐negative cases (OS: HR, 1.08; 95% CI, 0.81–1.45; p = 0.59).
Conclusions
In metastatic disease, MSI and EBV status were not associated with significant prognostic effects. MSI and EBV status have minimal prognostic value in gastric cancer, particularly for OS, but are essential for selecting candidates for immune checkpoint inhibitors. Standardizing biomarker evaluation is critical to enhancing their clinical relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oncology Unit, ASST Bergamo Ovest, Treviglio, Italy.
- Oncology Unit, ASST Crema, Crema, Italy.
- Oncology Unit, Casa di Cura Igea, Milano, Italy.
- Surgery Unit, ASST Bergamo Ovest, Treviglio, Italy.
- Surgery Unit, ASST Cremona, Cremona, Italy.
- Pathology Unit, ASST Bergamo Ovest, Treviglio, Italy.
ORCID-Profile: Fausto Petrelli, Maria Antista, Andrea Celotti
Zitieren
APA
Petrelli, F., Antista, M., Ghidini, A., Rampulla, V., Dottorini, L., Celotti, A., Cribiu, F. M., Galassi, B., Garrone, O., Zaniboni, A., Tomasello, G., & Ghidini, M. (2026). Prognostic Significance of MSI and EBV Positivity in PD ‐ L1 Positive Gastric Cancer: A Systematic Review and Meta‐Analysis. Cancer Medicine, 15(3). https://doi.org/10.1002/cam4.71711
Vancouver
Petrelli F, Antista M, Ghidini A, Rampulla V, Dottorini L, Celotti A, et al. Prognostic Significance of MSI and EBV Positivity in PD ‐ L1 Positive Gastric Cancer: A Systematic Review and Meta‐Analysis. Cancer Medicine. 2026;15(3). doi:10.1002/cam4.71711
BibTeX
@article{Petrelli2026,
author = {Petrelli, Fausto and Antista, Maria and Ghidini, Antonio and Rampulla, Valentina and Dottorini, Lorenzo and Celotti, Andrea and Cribiu, Fulvia Milena and Galassi, Barbara and Garrone, Ornella and Zaniboni, Alberto and Tomasello, Gianluca and Ghidini, Michele},
title = {Prognostic Significance of MSI and EBV Positivity in PD ‐ L1 Positive Gastric Cancer: A Systematic Review and Meta‐Analysis},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {3},
doi = {10.1002/cam4.71711}
}
EUVIMED